Acetyl-l-carnitine inhibits TNF-α-induced insulin resistance via AMPK pathway in rat skeletal muscle cells

FEBS Letters

Volumn 583, Issue 2, 2009, Pages 470-474

  Zhang, Zhaofeng ^a   Zhao, Ming ^a   Li, Qiong ^a   Zhao, Haifeng ^a   Wang, Junbo ^a   Li, Yong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Acetyl l carnitine; AMP activated protein kinase; Insulin resistance; Tumor necrosis factor

Indexed keywords

ADENYLATE KINASE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LEVACECARNINE; PROTEIN KINASE B; SERINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

ACETYLCARNITINE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MUSCLE, SKELETAL; PHOSPHORYLATION; RATS; SERINE; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 58149499155     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.12.053     Document Type: Article

References (26)

1. Qi C., and Pekala P.H. Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. Proc. Soc. Exp. Biol. Med. 223 (2000) 128-135
2. Makino N., Maeda T., Sugano M., Satoh S., Watanabe R., and Abe N. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells. J. Diabetes Complications 19 (2005) 347-355
3. Ohya M., et al. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism 54 (2005) 1297-1301
4. Shen W., et al. Protective effects of R-alpha-lipoic acid and acetyl-l-carnitine in MIN6 and isolated rat islet cells chronically exposed to oleic acid. J. Cell Biochem. 104 (2008) 1232-1243
5. Ido Y., McHowat J., Chang K.C., Arrigoni-Martelli E., Orfalian Z., Kilo C., Corr P.B., and Williamson J.R. Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-l-carnitine. Diabetes 43 (1994) 1469-1477
6. Sima A.A., Ristic H., Merry A., Kamijo M., Lattimer S.A., Stevens M.J., and Greene D.A. Primary preventive and secondary interventionary effects of acetyl-l-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J. Clin. Invest. 97 (1996) 1900-1907
7. Stevens M.J., Lattimer S.A., Feldman E.L., Helton E.D., Millington D.S., Sima A.A., and Greene D.A. Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na, K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat. Metabolism 45 (1996) 865-872
8. Sima A.A., Calvani M., Mehra M., and Amato A. Acetyl-l-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 28 (2005) 89-94
9. Quatraro A., Roca P., Donzella C., Acampora R., Marfella R., and Giugliano D. Acetyl-l-carnitine for symptomatic diabetic neuropathy. Diabetologia 38 (1995) 123
10. DeFronzo R.A., Jacot E., Jequier E., Maeder E., Wahren J., and Felber J.P. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30 (1981) 1000-1007
11. Dohm G.L., et al. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 82 (1988) 486-494
12. DeFronzo R.A., Bonadonna R.C., and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15 (1992) 318-368
13. Ritz E., and Orth S.R. Nephropathy in patients with type 2 diabetes mellitus. New Engl. J. Med. 341 (1999) 1127-1133
14. Giancaterini A., De Gaetano A., Mingrone G., Gniuli D., Liverani E., Capristo E., and Greco A.V. Acetyl-l-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism 49 (2000) 704-708
15. Ohsawa M., Miyata S., Carlsson A., and Kamei J. Preventive effect of acetyl-l-carnitine on the thermal hypoalgesia in streptozotocin-induced diabetic mice. Eur. J. Pharmacol. 588 (2008) 213-216
16. Stephens F.B., Constantin-Teodosiu D., and Greenhaff P.L. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J. Physiol. 581 (2007) 431-444
17. Mingrone G., Greco A.V., Capristo E., Benedetti G., Giancaterini A., De Gaetano A., and Gasbarrini G. l-Carnitine improves glucose disposal in type 2 diabetic patients. J. Am. Coll. Nutr. 18 (1999) 77-82
18. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996) 665-668
19. Steinberg G.R., et al. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 4 (2006) 465-474
20. Ruderman N.B., Saha A.K., Vavvas D., and Witters L.A. Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. 276 (1999) E1-E18
21. Stephens J.M., Lee J., and Pilch P.F. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272 (1997) 971-976
22. White M.F., and Yenush L. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr. Top. Microbiol. Immunol. 228 (1998) 179-208
23. Huang S., and Czech M.P. The GLUT4 glucose transporter. Cell Metab. 5 (2007) 237-252
24. Lin C.L., and Lin J.K. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Mol. Nutr. Food Res. 52 (2008) 930-939
25. Koepsell H., Gorboulev V., and Arndt P. Molecular pharmacology of organic cation transporters in kidney. J. Membr. Biol. 167 (1999) 103-117
26. Mutomba M.C., et al. Regulation of the activity of caspases by l-carnitine and palmitoylcarnitine. FEBS Lett. 478 (2000) 19-25